Company intelligence / Profile preview

Encycle Therapeutics Inc.

Toronto, Ontario, Canadaencycletherapeutics.com ↗
Ownership
Private
Employees
~5
Development stage
Other
01

Overview

Encycle Therapeutics is developing innovative cyclic peptide-based therapies to target previously undruggable proteins. Their platform technology enables the synthesis of stable, orally bioavailable cyclic peptides.

Therapeutic areas
Other
Modalities
Cyclic peptidesmacrocycles
Industry
Biotech
02

Partnerships

Zealand Pharma

Beyond the preview

Go deeper on Encycle Therapeutics Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Encycle Therapeutics Inc..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call